Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · IEX Real-Time Price · USD
37.93
+0.93 (2.51%)
Mar 28, 2024, 4:00 PM EDT - Market closed

Spyre Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014
Cash & Equivalents
189.2236.4216.9891.9420.7522.4612.8247.7529.372.66
Short-Term Investments
150.3820.8577.9956.1852.752.0537.4815.753.770
Cash & Cash Equivalents
339.657.2694.97148.1273.4574.5150.363.533.142.66
Cash Growth
493.04%-39.70%-35.88%101.66%-1.43%48.14%-20.79%91.61%1147.82%-
Receivables
00.380.820003.081.221.70
Other Current Assets
1.934.623.111.671.062.161.611.713.450.07
Total Current Assets
341.5362.2698.89149.7974.5176.6754.9966.4238.292.73
Property, Plant & Equipment
06.658.369.877.111.020.850.60.350.16
Other Long-Term Assets
0.332.242.681.961.570.050.230.040.020.04
Total Long-Term Assets
0.338.8911.0411.838.681.071.090.640.370.2
Total Assets
341.8671.14109.93161.6283.1877.7456.0867.0638.652.93
Accounts Payable
0.90.683.322.253.150.660.390.170.180.35
Deferred Revenue
02.73.580000.020.0700
Current Debt
00.630.440.320.3500000
Other Current Liabilities
31.0810.6612.8113.8714.859.585.223.732.350.71
Total Current Liabilities
31.9814.6620.1416.4418.3610.245.633.972.521.06
Long-Term Debt
044.615.134.7100000
Other Long-Term Liabilities
41.312.181.230.210.030.070.110.130.030
Total Long-Term Liabilities
41.316.185.845.344.740.070.110.130.030
Total Liabilities
73.2920.8425.9921.7923.110.315.744.12.551.06
Total Debt
04.635.045.455.0600000
Debt Growth
--8.23%-7.42%7.60%------
Retained Earnings
-764.41-425.62-341.81-276.01-195.12-116.86-72.51-45.28-23.58-12.28
Comprehensive Income
0.3-0.05-0.020.010.05-0.03-0.1-0-00
Shareholders' Equity
184.0250.3183.94139.8360.0867.4350.3462.97-22.21-11.47
Net Cash / Debt
339.652.6489.92142.6768.3974.5150.363.533.142.66
Net Cash / Debt Growth
545.20%-41.47%-36.97%108.62%-8.22%48.14%-20.79%91.61%1147.82%-
Net Cash Per Share
49.2415.6134.1966.8353.5189.4683.12162.131381.38402.42
Working Capital
309.5547.678.75133.3556.1566.4349.3662.4635.761.67
Book Value Per Share
26.6814.9231.9265.5047.0180.9583.18160.76-925.62-1738.33
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).